The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux.
about
Inhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to PraziquantelThe Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and RegulationModulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel.Anthelmintics are substrates and activators of nematode P glycoprotein.Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity.Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways.Schistosome ABC multidrug transporters: From pharmacology to physiology.A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fieldsAlbendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivityPharmacology and potential physiological significance of schistosome multidrug resistance transportersProlonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy.Intracellular accumulation of Praziquantel in T lymphoblastoid cell lines, CEM (parental) and CEMVBL(P-gp-overexpressing).Drug-transporter mediated interactions between anthelminthic and antiretroviral drugs across the Caco-2 cell monolayers.Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells.Bioenhancers from mother nature and their applicability in modern medicine.ABC multidrug transporters in schistosomes and other parasitic flatwormsPharmacokinetics of single-dose primaquine in patients with chronic kidney dysfunctionEchinacea sanguinea and Echinacea pallida extracts stimulate glucuronidation and basolateral transfer of Bauer alkamides 8 and 10 and ketone 24 and inhibit P-glycoprotein transporter in Caco-2 cellsNew approaches for understanding mechanisms of drug resistance in schistosomesSchistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibilityIn silico analysis of the binding of anthelmintics to Caenorhabditis elegansP-glycoprotein 1.Fexofenadine hydrochloride in the treatment of allergic disease: a reviewABC transporters involved in drug resistance in human parasites.Urinary schistosomiasis.Inhibitors of connexin and pannexin channels as potential therapeutics.Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia.Mefloquine-associated dizziness, diplopia, and central serous chorioretinopathy: a case report.Potential P-glycoprotein-mediated drug-drug interactions of antimalarial agents in Caco-2 cells.SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria.Transcriptomic profiling of the Saccharomyces cerevisiae response to quinine reveals a glucose limitation response attributable to drug-induced inhibition of glucose uptake.Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania.Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.Dissecting the components of quinine accumulation in Plasmodium falciparum.Enhanced absorption and bioavailability of hydrochlorothiazide by Chinese medicines in the Zhenju antihypertensive compound.Predicting apparent passive permeability of Caco-2 and MDCK cell-monolayers: A mechanistic model.In-vitro evaluation of the P-glycoprotein interactions of a series of potentially CNS-active Amaryllidaceae alkaloids.
P2860
Q28543846-DB84442B-DF93-4BC6-921B-295872D9B3F4Q28551177-7A0E54F4-A0B4-433D-90AD-D32C50FC2DFEQ33552868-D2EF3A37-B53F-45C5-B953-0037923F0D75Q33814196-81E78C7E-2298-4D4B-8CE5-20888058C0E2Q34233691-ED14E533-C4C4-42BB-99F7-7C3F04E87C74Q34496694-97331151-7F9F-4857-B3BE-66311604FBE6Q34705514-F10329A2-CD8F-4956-81AC-B8DD7D8A2009Q34754007-17C0C88C-8488-4C07-ADFB-5EADD2758B0CQ34830010-EC717B0B-5E0E-463A-B61A-7AC5FF489324Q35159499-659EB4A4-8893-4859-BAAD-76183D7A7B6EQ35841781-EBBF5BE1-FCEE-46C2-935C-87855CE93D59Q36103626-665BE0B6-A752-40DD-8806-E5828C0CE0F6Q36362462-0D0DEC2E-DC5C-4EF6-BC7D-1AB21453BBA0Q36734451-E3EC70F4-5510-4515-8B87-FD2F1FB49FA1Q36855754-CFF266A1-ECDE-47C9-A33D-282AE8922038Q37053762-1CACD411-DC77-473E-854E-189793746698Q37133285-DFB778C2-2780-42A7-9E80-26B9FC3B77ACQ37134477-70D3A7B7-AB4A-488D-97C4-725A2316D5DEQ37177725-10D6FEC6-6FFE-4B03-B701-559E76B55250Q37223703-13FB8179-A247-4FF7-B9EC-190F6992AEA6Q37541732-E7CF27CD-E6C3-4F9F-AA25-95D8209F9CECQ37857671-E1FD9E7A-F04B-4C20-8AC6-299003B4BF8CQ37941754-2E42CE8A-42A4-43F4-82D6-1274991B1D04Q38182412-01C329BB-08F2-462B-AEBB-A6C44277AA55Q39442549-E2AFBB2F-15A0-43AA-86A0-AA82CF9915F9Q39754914-753FF131-6DA0-4222-BB0C-EB6B7E5D278CQ41635121-A2019FC9-E3C1-4329-B292-29B247FB8190Q41774697-2E277201-64E5-43B0-B94D-BECDF8F12021Q41911842-F6D7AF8F-8C0F-44D8-95FF-3D2B8C688019Q42687537-E08AF529-F0FF-4D6C-940F-56CDF4F1CF66Q42849844-42EAD693-1586-4442-904B-E1202F7C4AEAQ46082627-0301B054-ED2C-401E-80FA-CF82F2A224C0Q46808989-89910FD9-E51B-4EE2-80A4-A050B583B483Q47683065-7154EE1C-C772-4C28-BE13-D8308C549DBDQ47739619-F66E5F4D-B34C-49EB-A48C-E1207B04CA8CQ47823537-0C9FAE2E-EC53-45BF-BCC2-5CBD578E38C9
P2860
The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The potential inhibitory effec ...... -glycoprotein mediated efflux.
@en
type
label
The potential inhibitory effec ...... -glycoprotein mediated efflux.
@en
prefLabel
The potential inhibitory effec ...... -glycoprotein mediated efflux.
@en
P2093
P1476
The potential inhibitory effec ...... -glycoprotein mediated efflux.
@en
P2093
Anna-Lena B Ungell
Rose Hayeshi
Stanley Mukanganyama
P356
10.1016/J.EJPS.2006.05.009
P407
P577
2006-06-03T00:00:00Z